3Kurnick J T, Ramirez-Montagut T, Boyle L A, et al. A novel autoerine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan A/ MART 1 antigen through down-modulation of its promoter[J]. J Immunol, 2001, 167(3): 1204-1211.
4Drake C G, JaVee E, Pardoll D M. Mechanisms of immune evasion by tumors[J]. Adv Immunol, 2006, 90: 51-81.
5Aptsiauri N, Carretero R, Garcia Lora A, et al. Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class Ⅰ antigen alterations[J]. Cancer Immunol Immunother, 2008, 57(11):1727-1733.
6Shimura T, Suehiro T, Suzuki H, et al. Peptides derived from a soluble molecule of the human leukocyte antigen (HLA) class Ⅰ cause apoptosis in gastric cancer cell lines[J]. Dig Dis Sci, 2009, 54(1) :63-69.
7Rubinstein N, Alvarez M, Zwirner N W, et al. Targeted inhibition of galectinq gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumorimmune privilege[J]. Cancer Cell, 2004, 5(3): 241-251.
8Strik H M, Schmidt K, Lingor P, et al. Galectin 1 expression in human glioma cells:modulation by ionizing radiation and effects on tumor cell proliferation and migration[J]. Oncol Rep, 2007, 18(2) : 483-488.
9Daroqui C M, Ilarregui J M, Rubinstein N, et al. Regulation of galectin-1 expression by transforming growth factor betal in metastatic mammary adenocarcinoma cells: implications for tumor immune escape[J]. CancerImmunol Immunother, 2007, 56(4): 491-499.
10Biswas K, Richmond A, Rayman P, et al. GM2 expression in renal cell carcinoma: potential role in tumor induced T-cell dysfunction[J]. Cancer Res, 2006, 66(13):6816-6825.
